U.S. RESEARCH ROUNDUP-Adobe, Caseys General Stores, Fedex
March 10 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Adobe, Caseys General Stores and Fedex on Tuesday.
HIGHLIGHTS
Adobe Inc ADBE.O: TD Cowen cuts target price to $325 from $400 |
Caseys General Stores Inc CASY.O: RBC raises target price to $713 from $662 |
Fedex FDX.N: JP Morgan raises target price to $424 from $294 |
Vertex Pharmaceuticals Inc VRTX.O: Oppenheimer raises target price to $600 from $540 |
Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday. Stock entries are in alphabetical order.
Chewy Inc CHWY.N: TD Cowen cuts target price to $39 from $48 |
Adobe Inc ADBE.O: TD Cowen cuts target price to $325 from $400 |
Arcbest Corp ARCB.O: JP Morgan raises target price to $90 from $81 |
Bridgebio pharma Inc BBIO.O: JP Morgan adds stock to its US analyst focus list |
Bridgebio pharma Inc BBIO.O: JP Morgan raises target price to $94 from $89 |
Caseys General Stores Inc CASY.O: RBC raises target price to $713 from $662 |
Coeur Mining, Inc CDE.N: CIBC initiates coverage with outperformer rating; PT $40 |
Everpure, Inc PSTG.N: Northland Capital raises to outperform rating |
Everpure, Inc PSTG.N: Northland Capital raises target price to $81 from $77 |
Fedex FDX.N: JP Morgan raises target price to $424 from $294 |
HCA Healthcare Inc HCA.N: TD Cowen raises target price to $561 from $529 |
Old Dominion Freight Line Inc ODFL.O: JP Morgan raises target price to $182 from $168 |
Oracle Corp ORCL.N: Baird cuts target price to $200 from $300 |
Semtech Corp SMTC.O: Oppenheimer raises target price to $100 from $81 |
target Corp TGT.N: D.A. Davidson raises target price to $140 from $120 |
Universal Health Services Inc UHS.N: RBC cuts target price to $216 from $245 |
US Physical Therapy USPH.N: Jefferies assumes coverage with buy rating; PT $102 vs $110 |
Vail Resorts Inc MTN.N: JP Morgan cuts target price to $156 from $172 |
Verisk Analytics Inc VRSK.O: Jefferies raises target price to $230 from $220 |
Vertex Pharmaceuticals Inc VRTX.O: Oppenheimer raises target price to $600 from $540 |
XPO Inc XPO.N: JP Morgan raises target price to $201 from $189 |
Related Articles
Micron vs. Samsung vs. SK Hynix: Is MU Stock the Best Memory Stock for 2026?
TradingKey - Relying on strong AI demand, more memory per system, and sluggish supply response, 2026 will be the memory cycle. Micron Technology (MU) is now in an excellent competitive position today with HBM3E and looking to ramp HBM4E into Nvidia’s Vera Rubin platforms in the second half of 2026.
Oil Prices Tumble Nearly $40 After Trump Signals End to War, Though Analysts Maintain Hormuz Strait Is the Real Decider
TradingKey - On Monday, March 9 (ET), Trump stated in an interview that the U.S.-Iran war has essentially ended, causing crude oil prices to plummet. Driven by the news, WTI and Brent crude futures, which had reached intraday highs near $120, dropped to the $80 mark.
Oracle Earnings Preview: Warner Bros is Becoming Central to Oracle's Future
How is the WBD Deal Affecting ORCL Stock?
Jensen Huang’s Bold Message: DRAM Fabs Should Expand, Nvidia Will Buy It All.
TradingKey - Nvidia (NVDA) CEO Jensen Huang recently delivered a powerful signal to global memory chip manufacturers at the Morgan Stanley Technology Conference: expand production with confidence, as Nvidia will take all available supply.
